Compare Fimperkasa Utama Tbk. (FIMP) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fimperkasa Utama Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Fimperkasa Utama Tbk. trades at Rp69 (market cap 27.6B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Organon Pharma Indonesia Tbk. is far larger — about 3.8× Fimperkasa Utama Tbk.'s market cap. Which is the better fit depends on your goals.
| FIMP | SCPI | |
|---|---|---|
Market Cap | 27.6B | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fimperkasa Utama Tbk.
PT Fimperkasa Utama Tbk (the "Company”) established in Indonesia based on Notarial Deed No. 41 of Adam Kasdarmadji, S.H., on February 08, 1993. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Mohamad Mulky Thalib,
Read more on FIMP →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
